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Expression of Beta-Glucosidase Increases Trichome Density and Artemisinin
Content in Transgenic Artemisia Annua Plants
Abstract
Artemisinin is highly effective against multidrug-resistant strains of Plasmodium falciparum, the
etiological agent of the most severe form of malaria. However, a low level of accumulation of artemisinin
in Artemisia annua is a major limitation for its production and delivery to malaria endemic areas of the
world. While several strategies to enhance artemisinin have been extensively explored, enhancing storage
capacity in trichome has not yet been considered. Therefore, trichome density was increased with the
expression of β glucosidase (bgl1) gene in A. annua through Agrobacterium-mediated transformation.
Transgene (bgl1) integration and transcript was confirmed by molecular analysis. Trichome density
increased up to 20% in leaves and 66% in flowers of BGL1 transgenic plants than Artemisia control plants.
High-performance liquid chromatography (HPLC, MS-TOF) data showed that artemisinin content
increased up to 1.4% in leaf and 2.56% in flowers (g-1DW), similar to the highest yields achieved so far
through metabolic engineering. Artemisinin was enhanced up to 5-fold in BGL1 transgenic flowers. The
present study opens the possibility of increasing artemisinin content by manipulating trichomes density,
which is a major reservoir of artemisinin. Combining biosynthetic pathway engineering with enhancing
trichome density may further increase artemisinin yield in A. annua. Because oral feeding of Artemisia
plant cells reduced parasitemia more efficiently than the purified drug, reduced drug resistance and cost
of prohibitively expensive purification process, enhanced expression should play a key role in making this
valuable drug affordable to treat malaria in a large global population that disproportionally impacts lowsocioeconomic areas and underprivileged children.
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Expression of Beta-glucosidase increases trichome density and
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Artemisinin is highly effective against multidrug-resistant strains of Plasmodium falciparum, the
etiological agent of the most severe form of malaria. However, a low level of accumulation of
artemisinin in Artemisia annua is a major limitation for its production and delivery to malaria
endemic areas of the world. While several strategies to enhance artemisinin have been extensively
explored, enhancing storage capacity in trichome has not yet been considered. Therefore, trichome
density was increased with the expression of β glucosidase (bgl1) gene in A. annua through
Agrobacterium-mediated transformation. Transgene (bgl1) integration and transcript was
confirmed by molecular analysis. Trichome density increased up to 20% in leaves and 66% in
flowers of BGL1 transgenic plants than Artemisia control plants. High-performance liquid
chromatography (HPLC, MS-TOF) data showed that artemisinin content increased up to 1.4% in
leaf and 2.56% in flowers (g-1DW), similar to the highest yields achieved so far through metabolic
engineering. Artemisinin was enhanced up to 5-fold in BGL1 transgenic flowers. The present
study opens the possibility of increasing artemisinin content by manipulating trichomes density,
which is a major reservoir of artemisinin. Combining biosynthetic pathway engineering with
enhancing trichome density may further increase artemisinin yield in A. annua. Because oral
feeding of Artemisia plant cells reduced parasitemia more efficiently than the purified drug,
reduced drug resistance and cost of prohibitively expensive purification process, enhanced
expression should play a key role in making this valuable drug affordable to treat malaria in a
large global population that disproportionally impacts low-socioeconomic areas and
underprivileged children.
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INTRODUCTION
Despite many advances in medical science, malaria is still a global issue with an estimated
198 million cases (uncertainty range: 124–283 million) occur every year worldwide (WHO,
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2014), in which the majority of cases (82%) were in the African region followed by SouthEast Asia (12%) and Eastern Mediterranean Regions (4.5%, WHO, 2014). It is estimated
that there were 584,000 malaria deaths globally in 2013 with about 82% of malaria cases
and 90% of malaria deaths occurring in children under 5 years of age in the African region
(WHO, 2014). Malaria is an entirely preventable and treatable disease, provided that the
currently recommended interventions are properly implemented (WHO, 2014). The widely
used antimalarial drug chloroquine, to control malaria, is now ineffective in most of
falciparum malaria endemic areas, and is resistant to sulfadoxine-pyrimethamine (WHO,
2014).
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Chinese researchers isolated artemisinin in the early 1970s from Artemisia annua, a herb of
the Asteraceae family (Klayman, 1985). Although organic synthesis of artemisinin is
possible, its low yield makes it economically nonviable as a mean of drug production (Avery
et al. 1992). Thus, isolation of artemisinin from A. annua still is the best alternative (De
Vries and Dien, 1996). Artemisinin is a sesquiterpenoid, produced in glandular trichomes of
Artemisia annua (Covello 2008). Currently available commercial artemisinin is mainly
extracted from wild plants which are subject to seasonal and environmental fluctuations.
Thus, artemisinin concentration varies with genotype (Charles et al., 1990; Jain et al., 1996),
plant tissue and time of harvesting (Laughlin, 1993, 1995; Morales et al., 1993; Ferreira and
Janick, 1995), and is influenced by soil and climatological conditions (Van Geldre et al.,
1997). Moreover, artemisinin content in A. annua is very low (0.01 - 1% dry weight, DW),
and the demand for artemisinin is increasing along with the increasing number of people
suffering from malaria (Qian et al., 2007). In an effort to increase artemisinin production,
various approaches have been attempted including chemical synthesis (Avery et al., 1992)
and genetic engineering of the pathway genes involved in artemisinin biosynthesis in A.
annua (Vergauwe et al., 1996; Chen et al., 2000; Xie et al., 2001; Martin et al., 2003; Ro et
al., 2006), but not much success has been achieved because of the complex nature of the
gene regulation and expression in artemisinin biosynthesis. Thus, engineering of A. annua
plants for increased artemisinin production still remains of great interest (Covello, 2008;
Graham et al., 2010).

Author Manuscript

Monotherapy with artemisinin alone has failed to clear malarial parasites completely in
some parts of the Asia (Sibley, 2015). Artemisinin-based combination treatments (ACTs)
with other anti-malarial drugs are now commonly used and considered the best current
treatment for uncomplicated falciparum malaria (WHO, 2014). Apart from malarial
parasites, artemisinin also has antiviral activities (Romero et al., 2006) and can be used in
treatment of hepatitis B (Romero et al., 2005) and for cancer treatment (Efferth et al., 2001).
Artemisinin has been considered to be a relatively safe drug with no obvious adverse
reactions or serious side effects, even for pregnant women (Dellicour et al., 2007). However,
access of artemisinin based combination therapy to patients is inadequate in all surveyed
countries (WHO, 2014).
The presence of glandular trichomes (GT) on the epidermis of the A. annua leaf is related to
biosynthesis of several secondary metabolites and impacts accumulation of artemisinin
(Kjær et al., 2012). However, molecular mechanism of artemisinin biosynthesis and the
development of trichomes in A. annua remains poorly understood (Tan et al., 2015). A laser
Plant Biotechnol J. Author manuscript; available in PMC 2017 March 01.
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dissection study of GT of A. annua (Olsson et al. 2009) showed that key enzymes of
artemisinin production were expressed exclusively in the two apical cells of GT. The
initiation and development of GT in the genus Artemisia is completed at a very young
primordial stage of the leaf development (Duke and Paul 1993), and density of GT of the
fully developed leaf in A. annua is predetermined at an early primordial stage (Davies et al.,
2009). The GT density observed highest at the maximum size of leaves; later density
decreased rapidly, suggesting that some GT are ruptured after maturity (Lommen et al.,
2006). In A. annua the number of GT increased as leaves reached full maturity and
decreased thereafter (Arsenault et al. 2010). Duke and Paul (1993) showed that the cuticle
covering the sub-cuticular storage area of the GT breaks in mature GTs and this influences
density of intact trichomes. Further, a study on the floral morphology of A. annua has shown
physiological maturity of GT in the inflorescence coincided with full bloom (Ferreira and
Janick, 1995). In the past, attempts have been made to enhance GT to increase accumulation
of artemisinin triggered by chemical or physical stress. However, such strategies have not
been successful in A. annua ((Kjær et al., 2012). The presence of low density of GT in A.
annua is responsible for the low accumulation of artemisinin (Kjær et al., 2012). Therefore,
and there is a strong positive relationship between artemisinin content and GT densities. The
relationship between GT densities, artemisinin content and key precursors was also
confirmed by Graham et al. (2010).
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Hormones play an important role in regulating plant growth and development (Davies,
2004). Plant vacuoles are known to be important reservoirs for storage of proteins, pigments,
inactive hormones and cyanogenic glycosides, which play an important role in cellular
homeostasis, plant defense mechanisms and detoxification (Taiz, 1992). Most of the
phytohormones are synthesized within the cell and then transported to different cellular
compartments, especially to the plant vacuoles. It has been reported that plant vacuoles are
reservoirs for a lot of inactive hormone conjugates (Sembdner et al, 1994; Schneider et al,
1994). Hydrolytic enzymes like glucosidases releases active phytohormones by enzymatic
cleavage of the glycosidic linkages in the glyco-conjugates (Jin et al 2011). Previously we
reported that expression of β-glucosidase in tobacco chloroplasts increases biomass
production as well as the number of trichomes (Jin et al, 2011). As pointed above, trichomes
have been implicated in the biosynthesis of artemisinin; therefore, we explored the role of βglucosidase in Artemisia annua. In the present study, bgl1 gene encoding β glucosidase
enzyme from Trichoderma reesei tagged with vacuole targeting sequence chitinase at the C
terminus was expressed in A. annua. The transgenic lines were characterized and transferred
to greenhouse and evaluated for density of trichomes and artemisinin content in leaves and
flowers.
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RESULTS
Creation and characterization of Artemisia annua transgenic lines
The binary transformation vector containing bgl1 gene with vacuolar targeting sequence
(Fig. 1A) was used to transform Artemisia annua leaf explants using Agrobacterium
tumefaciens LBA 4404. The transformation protocol was based on an earlier report with
minor modifications (Han et al., 2005). After 4-6 weeks, shoots were regenerated from the

Plant Biotechnol J. Author manuscript; available in PMC 2017 March 01.

Singh et al.

Page 4

Author Manuscript

leaf explants on selection medium (Fig. 1B) and resistant shoots were transferred to rooting
medium containing kanamycin 50-mg/l (Fig. 1C). PCR analysis confirmed integration of the
bgl1 gene into A. annua transgenic lines while no amplification was observed in the
untransformed plants (Fig. 1E). These transgenic lines were transferred to a greenhouse for
further growth and characterization. There was no phenotypic difference between transgenic
and untransformed plants (Fig. 1D). RNA was extracted from the PCR positive transgenic
lines and Bgl1 transcript was analyzed by northern blot with bgl1 gene specific probe (~0.6
Kb as shown in Fig. 1A). Bgl1 transcript was detected in all A. annua transgenic lines with
various levels of expression, whereas no transcript was observed in untransformed plants
(Fig. 1F).
Beta-glucosidase activity in transgenic lines and transgene copy number

Author Manuscript

Leaf samples were collected from transgenic and untransformed plants. β-glucosidase
activity was measured using p-nitrophenyl β-D-glucopyranoside (pNPG) as the substrate.
One unit of β-glucosidase is defined as the amount of enzyme that released 1 μmol of pnitrophenol from pNPG substrate under identical assay conditions. A. annua transgenic lines
(26-33 units per gram fresh leaves) showed a 1.6-2 fold increase in β-glucosidase activity
when compared to untransformed plants (16 units per gram mature fresh leaves) (Fig. 2A).
A. annua plants showing higher activity of BGL1 enzyme activity were further evaluated for
copy number of transgene Bgl1 by Southern blots. Transgenic lines showed multiple bgl1
transgene copies when probed using bgl1 gene specific probe (~0.6 kb) (Fig. 2B).
Evaluation of trichome structure and density

Author Manuscript

Trichomes in A. annua plants are epidermal outgrowth may have various functions
depending on the plant species and organs. However, the function of the GTs of this species
is unclear (Jessing et al., 2013). Scanning electron microscopy analysis revealed two types
of trichomes, glandular and filamentous trichomes on both surfaces of leaves (Fig 3A-H).
Similar results were obtained when leaf surface was observed under confocal laser
microscope (Fig. 4A). In both leaf surfaces, density of glandular trichomes was 10-20%
higher in Bgl1 transgenic lines when compared to untransformed plants (Fig. 5A & B). The
elliptical cross-sectional area of the glandular trichomes was also measured. Transgenic
lines showed up to 2-fold increase in cross-sectional area when compared to untransformed
plants (Fig. 5C). The density of trichomes in flowers of Bgl1 transgenic lines was also
observed under a stereomicroscope and compared with untransformed plants (Fig. 4B). One
capitulum contains 10-14 central and 8-10 marginal florets. The number of trichomes was
recorded for both florets. In A. annua transgenic lines, increase in trichome density in
flowers was up to 66 % when compared to untransformed plants (Fig. 7A).

Author Manuscript

Evaluation of Artemisinin content
A high-performance liquid chromatography (HPLC) system equipped with a 6224A time of
flight mass spectrometer (MS-TOF) was used to quantify artemisinin content in leaves
harvested at different developmental changes and flowers. Artemether was used as an
internal standard in all the samples (Fig. 6). The integrated extracted ion chromatograms
(EIC) of artemisinin [M+H]+adduct and artemether [M+Na]+ adduct peaks were obtained.

Plant Biotechnol J. Author manuscript; available in PMC 2017 March 01.
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The artemisinin content was variable among in A. annua transgenic lines and also depended
on the age and position of the harvested leaf samples (Table 1). The artemisinin content
increased was up to 66.5% when compared to untransformed plants depending on the
position and age of the leaf, while in some positions artemisinin content was lower than
untransformed plants (Table 2). Highest artemisinin content was up to 1.4 % (g-1DW) in
transgenic lines when compared to 1.22% (g-1DW) in untransformed plants. Artemisinin
content was also quantified in flowers. In one particular transgenic line 10.9A, artemisinin
content was 5 fold (2.56% g-1DW) more than untransformed flower (0.55% g-1DW, Fig. 7).
Chromatogram of artemisinin and internal standard artemether is shown in Fig. 6.

DISCUSSION
Author Manuscript
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Although the World Health Organization (WHO) recommends ACT as first-line treatment
for uncomplicated malaria caused by Plasmodium falciparum, there is great concern for
limitation of supplying artemisinin over 100 million treatments per annum in order to meet
the global requirement (Graham et al., 2010). It has been shown that the production of
artemisinin occurs in specialized 10-celled biseriate glandular trichomes present on the
leaves, stems and inflorescences of A. annua plants (Duke et al., 1994; Van Nieuwerburgh et
al., 2006). Recently it has been shown that expression of β-glucosidase in tobacco plants
releases active hormones, including GAs, from their conjugates stored within plastids and
facilitate a 740% to 1,033% increase in trichome density in transplastomic lines and also
increased leaf area (Jin et al., 2011). Therefore, substances that improve the leaf
development and shoot growth are presumed to increase artemisinin yield. In an effort to
increase the number of trichomes, Artemisia bgl1 transgenic lines were regenerated via
Agrobacterium-mediated transformation. Many T0 transgenic lines were obtained and Bgl1
gene integration and copy number was confirmed by PCR and Southern blot, respectively.
Northern blot analysis showed different levels of Bgl1 transcript between each individual
line. This variation in transcript levels is not uncommon in nuclear transgenic lines and
could be due to their site of integration (position effect), gene silencing, etc. However, Bgl1
enzyme unit per g/DW was 2 fold higher in transgenic plants than untransformed plants,
which suggests that transgene expressed in Artemisia annua is functional.

Author Manuscript

Results of Van Nieuwerburgh's group (2006) supports the hypothesis that artemisinin and
some of its structural analogs present in the leaves A. annua L. are localized entirely within
the sub-cuticular space of glands on the leaf surface. The number of GT on leaves is directly
proportional to artemisinin accumulation (Arsenault et al., 2010; Graham et al., 2010; Kjær
et al., 2012). In our study, artemisinin content was higher in the sub-cuticular space of GTs
of Bgl1-transformed plants than untransformed control plants. This suggests that larger size
of the GTs may be associated with larger sub-cuticular space resulted due to BGL1
expression.
Scanning electron microscopic and confocal microscopic analysis have shown that density
of glandular trichomes in leaf samples was 10-20% higher in most of the bgl1 transgenic
lines when compared to untransformed plants (Fig. 5A & B). It has been reported that the
application of phytohormones can increase cross sectional area of the trichome when
compared to untreated Artemisia plants (Maes et al., 2011). In order to assess glandular
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trichome size, 4 transgenic lines were selected and a cross-sectional area of each individual
glandular trichomes was measured. Notably, in addition to gland density, gland size also
differed between each individual transgenic line (Fig. 5C). A. annua transgenic lines have
larger glandular trichomes than untransformed plants. The presence and development of
glandular trichomes in the inflorescences was also associated with artemisinin production
based on extraction studies (Ferreira and Janick 1995). The glandular trichomes are greater
in the corolla and receptacles florets than in leaves, stems, or bracts. Although these glands
are present at the early stage of development on both leaves and inflorescences, artemisinin
increases at anthesis, suggesting that it accumulates as the glands reach physiological
maturity, a stage which coincides with the end of cell expansion in floret development
(Ferreira and Janick 1995). Thus, mature flowers were dissected under stereomicroscope and
trichome density was analyzed. Mature flowers of A. annua transgenic lines showed 1166% increase in trichome density when compared to untransformed plants. Large
differences in artemisinin content have been reported, depending on genotype (variety),
season (environmental changes), cultivation condition (soil nature) and plant developmental
stage (Ferreira et al., 1995; Wallaart et al., 2000; Delabays et al., 2001; Yang et al., 2009).
HPLC (MS-TOF) data shows variation in individual A. annua plants and different samples.
This is in agreement with the various reports, which explains the influence of developmental
stages of plants on artemisinin content. Some researchers believe that the artemisinin content
reaches its peak before flowering (Abdin et al., 2003; Mauji Ram et al., 2010), while others
have indicated the peak occurs at the full-flowering stage (Ferreira et al., 1995a). From the
data presented here, it is clear that the accumulation of artemisinin is closely correlated with
trichome density and stages of leaves vary between individual plants. This variation in
trichome density among A. annua transgenic lines could be due to their site of integration
(position effect), gene silencing, etc. However, considerable evidence suggests that the
variation in artemisinin content in different organs is correlated with the density of
trichomes. This is in agreement with our data although variations are also observed within
individual lines. The association of artemisinin with glandular trichome sequestration
explains why artemisinin was not detected in parts of the plant that do not bear glands, such
as pollen or roots (Ferreira et al. 1995a) or in a glandless biotype (Duke et al. 1994).
Recently, Jessing et al. (2013) reported that roots could produce very small amounts of
artemisinin.
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Several genes are involved in artemisinin biosynthetic pathways, which could be
manipulated to increase the artemisinin content. Since artemisinin is stored in trichomes,
there is need for storage room for large amounts of artemisinin synthesized from the overexpression of these genes. Thus the present study will open the possibility of increasing
artemisinin content by manipulating trichome density. The present study is based on T0
transgenic lines, but further investigation is needed in T2/T3 homozygous transgenic lines
where uniform trichome density and Bgl1 expression is expected. In order to achieve an
even higher trichome density, chloroplast genome of A. annua should be transformed using
the Bgl1 gene. However, chloroplast transformation has not yet been developed for this
species.

Plant Biotechnol J. Author manuscript; available in PMC 2017 March 01.
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Several questions should be addressed in further research. Why engineering of A. annua for
increasing artemisinin yield has limited success so far? One answer is that it is due to a
bottleneck of GT densities in foliar surface of A. annua as we observed in the present study.
Thus, genetic modifications to the enzymatic pathway and enhancement of GT density
would be important for enhanced artemisinin production. While several strategies to
enhance artemisinin have been extensively explored, enhancing storage capacity has not yet
been critically considered. This study shows that when GT density was increased artemisinin
content was also increased in A. annua. In the wild type, densities of GT of the fully
developed leaf in A. annua are predetermined at the early primordial stage (Davies et al.,
2009), which may be a disadvantageous factor to enhance the yield. On an average A. annua
produces ~ 0.1 to 1% artemisinin in the wild type depending on location and climatic
conditions. Bgl1 transgenics produced artemisinin content on per gram dry weight (g-1DW)
basis 1.4% (leaf) and 2.56% (flower), which is similar to the highest yield ~1.5% (15.1 mg/g
DW) reported so far via overexpression of three (ADS, CYP71AV1 and CPR) transgenes
(Lu et al. 2013). Combining these two approaches, an increase of GT densities via Bgl1 gene
and introduction artemisinin biosynthetic pathway may be advantageous for further
enhancement of artemisinin yield in A. annua. Artemisinin is lost during the rainy season
due to disruption of trichomes. Artemisinin was measured up to 8 mgL-1 in rainy water
suggesting that rain drops disrupt artemisinin-containing trichomes (Soetaert et al., 2013),
again underscoring their importance. Relatively little is known about the regulation of
artemisinin biosynthesis in A. annua plants, and the development of the specialized organ
like the glandular trichome. A. annua transgenic lines created in this study could be useful to
understand some of these important questions.
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Despite progress made in understanding the malarial parasite, expression of malarial vaccine
antigens (Davoodi-Semiromi et al 2010; Jones et al 2013), ability to produce low cost
vaccines free of cold storage (Kwon et al 2013, Lakshmi et al 2013), developing an effective
human vaccine against malaria is still elusive. Until then, drugs like artemisinin are the only
hope to save lives. A more exciting new development in this field is oral delivery of dried A.
annua leaves. When fed orally A. annua reduces parasitemia in rodent malaria more
effectively than purified artemisinin drug (Elfawal et al., 2012). Most interestingly, feeding
Artemisia annua plant cells to suitable animal models overcomes malarial parasite resistance
more effectively than pure artemisinin. Stable resistance to this drug evolved three times
slower than stable resistance to pure artemisinin drug (Elfawal et al., 2015).
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Unfortunately, these reports on oral feeding of Artemisia (Elfawal et al 2012, 2015) did not
explain the concept of bioencapsulation of this drug within plant cells but interpreted that
this could be due to protection of flavonoids or other antioxidants present in plants or animal
feed (which should be available for control animals fed with plant materials) or any other
synergistic effect. However, we have previously shown that plant cells protect
biopharmaceuticals from acids and enzymes in the stomach via bioencapsulation but gut
microbes release these drugs in the gut lumen by the action of commensal microbes, where
they are absorbed and delivered to the blood circulation system (Limaye et al., 2006; Kwon
et al., 2013a,b; Sherman et al., 2014; Kohli et al., 2014; Shil et al., 2014). Human digestive
enzymes are incapable of breaking down glycosidic bonds in carbohydrates that make up
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plant cell wall. However, when intact plant cells containing drugs reach the gut, commensal
microbes digest the plant cell wall and release drugs. Gut microbes have evolved to
breakdown every component of plant cell wall (Martens et al., 2011; Flint et al., 2008).
Therefore, artemisinin bioencapsulated in plant cells provides higher efficacy than pure
artemisinin drug delivered orally because it is degraded by gastric enzymes or acids
minimizing, thereby reducing bioavailability. Most importantly, the primary cost of
artemisinin is not in the growth of plants per se but the purification process is expensive.
Elimination of this step should make artemisinin affordable to global population that
disproportionally impacts those living in low-socioeconomic areas and underprivileged
children. The demand for artemisinin is quite high (170 metric tons required annually for
India). Although this drug is heavily subsidized, it still costs 10-40 times higher than other
antimalarial drugs. Considering the fact that one third of global population earn <$2 per day,
increasing artemisinin content and utilizing novel delivery methods are highly desirable.

Author Manuscript

MATERIALS AND METHODS
Plant materials and tissue culture conditions
Seeds of Artemisia annua L. were surface sterilized by soaking in 1.5% NaOCl for 10 min
after immersing in 70% ethanol for 1 min. Seeds were rinsed 5 times with sterile distilled
water and then germinated on MS medium (MS salt containing 2 mg/l glycine, 0.1 mg/l
thiamine, 0.5 mg/l pyridoxin, 0.5 mg/l nicotinic acid, 100 mg/l myo-inositol, 3% (w/v)
sucrose, 0.4 % (w/v) phytoblend, pH 6.1).
Construction of transformation vector
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Full-length cDNA of bgl1 gene (U09580) was amplified from genomic DNA of T. reesei
(American Type Culture Collection) as described previously (Jin et al., 2011) and fused with
vacuole targeting sequence Chitinase (CTPP) at C terminus. The fusion gene was cloned
into a pCR BluntII Topo vector (Invitrogen). After sequence confirmation, the fusion gene
was digested with Sma1 and Xba1 and ligated into a pCAMBIA 2300S transformation
vector. The neomycin phosphotransferase (nptII) was included in the construct to serve as a
selectable marker. The nptII gene confers resistance to antibiotic kanamycin. Both genes
were regulated by a 35S CaMV promoter. A polyA tail is included downstream to both
genes. The complete expression cassette was then transformed into the Agrobacterium
tumefaciens LBA 4404.
Transformation of A. annua

Author Manuscript

Agrobacterium tumefaciens cells were cultured in YEP agar medium supplemented with
antibiotics rifamycin (50 mg/l) and Kanamycin (50 mg/l) and were incubated overnight at
25°C. A loop full of the inoculum was grown in YEP liquid medium supplemented with 50
mg/l of rifamycin/kanamycin and incubated overnight at 25°C. Transformed cells were
collected by centrifugation. The pellet was then resuspended in Artemisia regeneration
liquid medium and then diluted to obtain an OD of 0.1 at 600 nm. Leaf explants were
harvested from 10 to 14 week old in vitro germinated Artemisia plants. Leaf pieces were
inoculated with Agrobacterium suspension culture for 20 min and co-cultured for 2 days at
25°C in the dark. Then explants were washed with sterile distilled water 3-4 times until no
Plant Biotechnol J. Author manuscript; available in PMC 2017 March 01.
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bacterial turbidity was observed, followed by a final wash with water containing antibiotic
cefotaxime (400 mg/l) to kill the bacteria. Following washing, explants were blotted dry and
transferred on regeneration medium (MS medium + NAA 0.05 mg/l + BA 1.0 mg/l, pH 6.1)
containing Kanamycin (35 mg/l) and cefotaxime (500 mg/l). Regenerated shoots were
transferred to rooting medium (MS medium + NAA (0.05 mg/l) supplemented with
kanamycin (15 mg/l) and cefotaxime (400 mg/l).
Evaluation of transgene integration
Genomic DNA was extracted form untransformed and transgenic A. annua lines using
Qiagen DNAesy extraction kit (Qiagen). PCR was set up using bgl1 gene specific forward
and reverse primers (F- 5′ GACACCATGCTGACTCTTGAATCAAGGTAGC 3′ and R 5′
GTCACTTGGCCAGAGTTTGCGATGTCAACG 3′) designed based on the bgl1 gene
(accession No. U09580) to yield 2.0 kb PCR amplified product.
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Evaluation of bgl1 transcript by northern blots
Total RNA was extracted from A. annua transgenic lines and untransformed plants using
INTRON easy-BLUE plant RNA extraction kit following the manufacturer protocol (Boca
Science). All apparatus and reagents were prepared and treated with diethyl pyrocarbonate
(DEPC) treated water to inhibit RNase activities. Total RNA was separated on 1% agarose
gel and transferred to nylon membrane. Further, the blot was hybridized with bgl1 gene
specific probe as performed below for Southern blot.
Functional enzyme assay and copy number of transgene

Author Manuscript

Total soluble protein was extracted from 1 g of fresh leaf tissue ground in liquid nitrogen
using 2 ml of ice-cold 100 mM citrate buffer (pH 5.2) which included protease inhibitor
cocktail (Roche). Protein concentration was measured by Bradford method using the BioRad protein assay kit. Beta-glucosidase activity was estimated as described by Berghem and
Pettersson (1974). In brief, 100 μg of total soluble protein (TSP) was incubated with 4mM
pNPG (Sigma) in 1ml of 100 mM citrate buffer, pH 5.2 at 50°C for 1 h. Addition of 2 ml of
1 M Na2CO3 terminated the reaction. Enzymatic release of nitrophenol was determined by
spectrophotometer at 405 nm. The standard curve of p-nitrophenol was prepared under
alkaline conditions using 1 M Na2CO3. One pNPG unit is defined as 1 μmol of pnitrophenol release per min at 50 °C.
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Transgenic lines that showed higher expression of BGL1 enzyme were evaluated for copy
number of transgene using Southern blot. In brief, 10 μg of genomic DNA was digested with
HindIII and separated onto 0.8% agarose gel. Further, the gel was transferred to nylon
membrane and hybridized with 32P dCTP labeled bgl1 gene probe (~0.6kb, isolated from
pCAMBIA 2300S with restriction enzymes EcoRI and BamHI) the Stratagene Quick-Hyb
hybridization solution and protocol. Confirmed transgenic lines were transferred to jiffy
pellets and after acclimatization in the growth room, plants were transferred to the
greenhouse for further studies.
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Evaluation of trichomes in leaves by SEM and confocal microscope
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A. annua leaves were washed with distilled water. Drops of fixative (2.5% glutaraldehyde
and 2% paraformaldehyde in 0.1 M phosphate buffer) were added in a petri dish or on a
glass plate and small pieces (2 mm) were dissected from mature leaves of transgenic and
untransformed (UT) plants in the presence of the fixative and fixed for 3 to 4 h at room
temperature. Tissues were washed with 0.1 M phosphate buffer four times for 15 min each
and then rinsed with distilled water three times for 5 min each. Then, tissues were
dehydrated with a graded series of ethanol: 30% ethanol for 10 min; 50% to 70% to 80% to
90% to 95% ethanol for 20 min each; and finally, 100% ethanol for 20 min three times. Leaf
cross-sections were loaded into a gasket and placed into the critical point drier (Bomb;
Electron Microscopy Sciences). After drying, samples were placed on carbon strips facing
up. Gold- Palladium was coated with the Emitech K 550 Sputter Coater for 2 min to reach
200 A°. Pieces were excised and examined with a Hitachi S-3500N scanning electron
microscope. The densities of trichomes were determined on both the upper and lower
surfaces of leaves. A. annua leaf surfaces were also directly observed under confocal
microscope (Leica). Images within the same section of a figure were taken using identical
confocal settings.
Measurement of glandular trichome cross-sectional area
Elliptical cross-sectional area of the glandular trichome was calculated as described in Maes
et al., 2011. In brief, the major (a) and minor (b) axes of the ellipse of the trichomes were
measured using ImageJ program (version 1.37; http://rsb.info.nih.gov/ij/). Then crosssectional area was calculated according to the formula, area = ABπ/4.
Evaluation of trichomes in floral structures
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Mature flowers from untransformed and A. annua transgenic lines were harvested and three
individual capitulum were dissected under the stereo microscope. Central and marginal
florets were analyzed under the stereomicroscope. One capitulum contains 10-14 central and
8-10 marginal florets. The number of trichomes was recorded for both florets.
Evaluation of artemisinin content

Author Manuscript

Leaf samples were harvested from different positions of the individual plants and then dried
for 24 h in an oven at 50°C. Flowers were also harvested from different A. annua transgenic
lines. The dried plant material was ground to fine powder. Exactly 100 mg of powder was
extracted in 20 ml hexane in an ultrasonic bath for 30 min. The supernatant was transferred
to a 40 ml glass vial and evaporated to dryness under nitrogen gas. The residue was
resuspended in 5 ml acetonitrile and filtered through a nylon filter (0.45 μm) attached to a 5ml syringe used for artemisinin quantification.
Quantification of artemisinin by HPLC MS-TOF
Quantification was performed using high-resolution mass spectrometry with an Agilent
Technologies 1200 series high-performance liquid chromatography (HPLC) system
equipped with a 6224A time of flight mass spectrometer (MS-TOF) using electrospray
ionization (ESI) operating in positive mode.. The mobile phases used were pump A, 1 mM
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ammonium acetate buffer, pH 5 (adjusted using acetic acid), and pump B, Methanol. With a
flow gradient at 200 μl/min, the gradient mobile phase composition was 50% mobile phase
B for 0.5 min, then linearly increased to 80% mobile phase B for 3.5 min and maintained
80% mobile phase B for 11 min. The total run time was 15 min. Separation was performed
on a phenomenex Luna C18 (2) 2.00 × 100mm column with C18 2.00 × 4 mm guard column
with peaks of interest eluting at 6.7 min for artemisinin and 10.5 min for artemether. The
ESI capillary voltage was set to 3.5kV. The nitrogen nebulizing gas was set to 325°C, 12 l/
min, and 40 psig. A standard curve was established over a range of five concentrations of
artemisinin (1, 4, 16, 64, 256 ng/ml) while using a 5 μM artemether internal standard. The
ratio of integrated extracted ion chromatograms (EIC) of artemisinin [M+H]+ adduct and
artemether [M+Na]+ adduct peaks were used to construct a standard curve. Sample filtrate
was serially diluted 1:100 twice using a diluent containing a 50:50 mixture of mobile phases
A:B and 5μM artemether internal standard. An injection volume of 25 μl was used.
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Figure 1. Transformation and molecular characterization of A. annua transgenic plants
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(A) Schematic representation Agrobacterium transformation vector. (B) Putative Bgl1
transformants growing on regeneration selection medium containing kanamycin. (C) Bgl1 A.
annua transgenic lines on rooting medium containing kanamycin. (D) Bgl1 transgenic lines
grown in the greenhouse. (E) Confirmation of bgl1 gene integration by PCR. (F)
Confirmation of Bgl1 transcript level of different transgenic lines by northern blot analysis
using bgl1 gene probe (Lanes 1–7: Bgl1 transgenic lines; Lane 8: Untransformed plant).
GOI: His Bgl1 Chitinase CTPP; Bgl1 Chitinase CTPP.
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Figure 2. Evaluation of A. annua BGL-1 enzyme yield and transgene copy number
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One unit of BGL-1 enzyme is defined as the amount of enzyme that released 1 μmol of pnitrophenol from pNPG substrate under the assay conditions described in “Materials and
Methods. UT :untransformed plants; T: Bgl1 transgenic plant. (B) The plant showing higher
activity of enzyme BGL1 in comparison to UT were further tested for copy number of Bgl1
by Southern blot using bgl1 gene specific probe (~0.6 kb) cut out from the vector using
unique restriction sites EcoRI and BamHI. UT: untransformed; A. annua transgenic lines
7.1D, 10.4, 10.9, 10.9A.
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Figure 3. Evaluation of trichome density on leaf surface by scanning electron microscopy
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(A and B) Untransformed plant; (C to H) Bgl1 A. annua transgenic lines randomly selected
for analysis showing higher trichome density.
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Figure 4. Evaluation of trichome density in A. annua leaves and flowers
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(A) Density of trichomes on both the leaf surface observed under confocal microscope. (B)
Density of trichomes in flowers. Three individual capitulum were collected and central and
marginal florets were analyzed under light microscope. One capitulum contains 10-14
central and 8-10 marginal florets. The number of trichome was recorded for both florets.
UT: untransformed plants; 7.1D, 10.4, 10.9 and 10.9A: Bgl1 A. annua transgenic plants.
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Figure 5. Comparison of trichome density and cross-sectional area of leaf samples

Author Manuscript

(A) Density of trichomes on dorsal surface (A) and ventral surface (B). Gland size (C).
Numbers in the ordinate indicate the mean cross-sectional area of the gland. Elliptical crosssectional areas of the glandular trichomes, the major (a) and minor (b) axes of the ellipse
were measured with the program ImageJ (version 1.37; http://rsb.info.nih.gov/ij/). The area
was calculated according to the formula, area = ABπ/4. UT: untransformed plants; 7.1A,
7.1C, 7.1D, 7.1E, 10.4, 10.9 and 10.9A: Bgl1 transgenic plants.
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Figure 6.

Author Manuscript

Chromatogram of artemisinin and internal standard artemether analyzed by highperformance liquid chromatography (HPLC) system equipped with a 6224A time of flight
mass spectrometer (MS-TOF)
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Figure 7. Number of trichome and quantification of artemisinin

(A) Evaluation of trichome density in central and marginal florets. (B) Comparison of
artemisinin content in Bgl1 transgenic and untransformed plants. UT: untransformed plants;
7.1D, 10.4, 10.9 and 10.9A: Bgl1 transgenic plants.

Author Manuscript
Author Manuscript
Plant Biotechnol J. Author manuscript; available in PMC 2017 March 01.

Singh et al.

Page 22

Table 1

Author Manuscript

Quantification of Artemisinin from different leaf samples of Bgl1 transgenic and untransformed plants (%
Artemisinin/gram DW). UT: Untransformed; 7.1D, 7.1A, 7.1C, 7.1E, 10.4, 10.9 and 10.9A: Bgl1 transgenic
lines were grown under same conditions in the greenhouse. Quantification of artemisinin is provided as an
average ± standard deviation of 3 replicates.
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Position

UT

7.1D

7.1A

7.1C

7.1E

10.4

10.9

10.9A

Top (Young)

0.84±0.02

1.21±0.04

0.87±0.03

0.33±0.22

0.87±0.03

0.78±0.02

0.81±0.01

1.40±0.02

Top (Mature)

1.15±0.02

1.37±0.06

0.68±0.07

0.42±0.12

0.87±0.01

0.72±0.09

1.11±0.01

0.93±0.02

Top (Old)

1.11±0.01

1.39±0.03

0.86±0.05

0.67±0.02

0.64±0.2

0.74±0.10

0.95±0.03

0.69±0.01

Middle (Young)

1.17±0.03

1.00±0.06

0.55±0.06

0.49±0.09

0.88±0.04

0.73±0.03

0.53±0.01

1.06±0.02

Middle (Mature)

0.97±0.03

1.31±0.03

0.82±0.03

0.64±0.05

1.00±0.1

0.77±0.10

0.88±0.02

0.63±0.03

Middle (Old)

1.02±0.04

1.11±0.01

1.12±0.06

1.03±0.07

1.26±0.05

0.85±0.01

0.88±0.07

0.98±0.01

Bottom (Young)

1.22±0.03

0.87±0.01

0.98±0.01

0.90±0.28

0.89±0.1

1.01±0.02

0.53±0.10

1.32±0.02

Bottom (Mature)

0.93±0.03

1.15±0.06

0.87±0.02

1.11±0.03

0.86±0.02

0.92±0.01

0.68±0.09

0.72±0.04

Bottom (Old)

0.82±0.02

0.90±0.06

1.17±0.02

1.24±0.01

1.10±0.35

1.18±0.03

0.69±0.01

0.84±0.01
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Table 2

Author Manuscript

Highest percentage increases of artemisinin content per gram DW in Bgl1 transgenic lines. Results were
analyzed using t-test (www.graphpad.com) on artemisinin content in transgenic lines in leaves at different
stages of development when compared to untransformed plants at identical stages of development and grown
under similar conditions. A single asterisk represents significant difference at P< 0.01 and triple asterisk
represents a highly significant difference at P< 0.0001 between transgenic and untransformed lines.
7.1D

7.1A

7.1C

7.1E

10.4

10.9A

43% in top young
leaf***

42% in bottom old
leaf***

51% in bottom old
leaf***

34% in bottom old
leaf***

43% in bottom old
leaf***

66.5% in top young
leaf***
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